🇺🇸 FDA
Patent

US 11963533

Compositions and methods for treating Liberibacter diseases and other bacterial diseases

granted A61KA61K38/00A61K45/06

Quick answer

US patent 11963533 (Compositions and methods for treating Liberibacter diseases and other bacterial diseases) held by The Regents of the University of California expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61K45/06